Regenxbio Inc recently announced that the company expects to hold a Type A meeting with the U.S. Food and Drug Administration (FDA) in July this year.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
This meeting aims to hold key discussions regarding the relevant Biologics License Application (BLA). After the meeting, the company plans to act swiftly and resubmit the BLA application within the third quarter of 2026. This timeline highlights the company’s determination and efficiency in advancing its research and development pipeline.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
JPMorgan Chase: SpaceX Inclusion in Nasdaq 100 Index Could Trigger $4.3 Billion Passive Fund Inflows
BlockBeats•2026/06/27 09:54
Exchange leads you to trending coins: AAVE's popularity rises, up 11.53% in 24H
AiCoin•2026/06/27 09:33
NAVI Protocol incubates Premium Exchange ecosystem token PST, which will soon be launched
Chaincatcher•2026/06/27 09:16
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$60,307.76
+1.02%
Ethereum
ETH
$1,579.4
+1.69%
Tether USDt
USDT
$0.9985
-0.01%
USDC
USDC
$0.9997
+0.01%
XRP
XRP
$1.06
+2.51%
Solana
SOL
$71.67
+3.93%
TRON
TRX
$0.3205
-0.47%
Hyperliquid
HYPE
$62.76
-0.01%
Dogecoin
DOGE
$0.07522
+1.74%
Zcash
ZEC
$407.23
+1.61%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now